Dodge & Cox

Holding/activity history for  BioMarin Pharmaceutical Inc. (BMRN)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2024   Q1 8,914,025 0.72 $87.34
2023   Q4 8,914,025 0.88 $96.42
2023   Q3 8,914,025 0.87 Add 0.53% 0.00 $88.48
2023   Q2 8,867,025 0.85 Add 0.36% 0.00 $86.68
2023   Q1 8,834,825 0.98 $97.24
2022   Q4 8,834,825 1.05 Reduce 1.89% 0.02 $103.49
2022   Q3 9,005,225 1.07 Add 0.21% 0.00 $84.77
2022   Q2 8,986,725 0.89 $82.87
2022   Q1 8,986,725 0.72 $77.10
2021   Q4 8,986,725 0.83 $88.35
2021   Q3 8,986,725 0.77 Add 6.08% 0.04 $77.29
2021   Q2 8,471,425 0.81 Add 25.51% 0.16 $83.44
2021   Q1 6,749,860 0.65 Add 22.19% 0.12 $75.51
2020   Q4 5,524,125 0.69 Add 33.33% 0.17 $87.69
2020   Q3 4,143,160 0.52 Add 78.10% 0.23 $76.08
2020   Q2 2,326,325 0.48 Reduce 7.73% 0.04 $123.34
2020   Q1 2,521,325 0.42 Reduce 14.71% 0.07 $84.50
2019   Q4 2,956,325 0.34 Buy 0.34 $84.55